Gallery of new files
Jump to navigation
Jump to search
This special page shows the last uploaded files.
-
Avelumab Dosage and Monitoring Table.png Yashasvi Aryaputra
17:06, 27 June 2018
738 × 2,538; 1.11 MB
-
Avelumab Patient Counseling Information.png Yashasvi Aryaputra
15:57, 27 June 2018
482 × 2,786; 1.12 MB
-
Avatrombopag Adverse Reactions Table.png Yashasvi Aryaputra
02:51, 27 June 2018
1,304 × 1,122; 187 KB
-
Avatrombopag Molecular Structure WIKI.png Yashasvi Aryaputra
02:38, 27 June 2018
2,366 × 1,286; 343 KB
-
Avatrombopag Pharmacokinetics Table.png Yashasvi Aryaputra
02:31, 27 June 2018
1,296 × 1,310; 208 KB
-
Avatrombopag Clinical Studies Table.png Yashasvi Aryaputra
02:23, 27 June 2018
1,182 × 1,670; 930 KB
-
Avatrombopag Patient Couseling Information.png Yashasvi Aryaputra
02:11, 27 June 2018
758 × 2,314; 1.21 MB
-
Focal segmental glomerulosclerosis - high mag.jpg Manpreet Kaur
16:00, 26 June 2018
4,272 × 2,848; 4.4 MB
-
Drug-induced interstitial nephritis, with prominent eosinophilic.png Mohsen Basiri
06:30, 26 June 2018
494 × 335; 464 KB
-
Apalutamide Adverse Reactions Table 1.png Yashasvi Aryaputra
17:37, 25 June 2018
778 × 2,318; 884 KB
-
Angiotensin II (Giapreza) Pharmocology Box Image.png Yashasvi Aryaputra
15:31, 25 June 2018
2,598 × 1,390; 551 KB
-
Angiotensin II (Giapreza) Package Label 2.jpeg Yashasvi Aryaputra
15:24, 25 June 2018
1,372 × 1,151; 143 KB
-
Angiotensin II (Giapreza) Package Label 1.jpeg Yashasvi Aryaputra
15:23, 25 June 2018
725 × 240; 39 KB
-
Apalutamide Patient Counseling Information.png Yashasvi Aryaputra
03:15, 25 June 2018
650 × 2,540; 1.25 MB
-
Apalutamide Clinical Studies Figure and Table.png Yashasvi Aryaputra
03:00, 25 June 2018
1,070 × 1,682; 659 KB
-
Neurovascular compression of the trigeminal root.jpeg Simraa.K
19:38, 23 June 2018
506 × 1,280; 112 KB
-
Angiotensen ll (Giapreza) Dosage Table.png Yashasvi Aryaputra
17:19, 20 June 2018
1,034 × 460; 71 KB
-
Angiotensin II (Giapreza) Molecular Structure.png Yashasvi Aryaputra
17:13, 20 June 2018
1,338 × 556; 258 KB








































